4//SEC Filing
Rizvi Qasim 4
Accession 0001179110-20-003834
CIK 0001730430other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:22 PM ET
Size
5.4 KB
Accession
0001179110-20-003834
Insider Transaction Report
Form 4
Rizvi Qasim
Chief Commercial Officer
Transactions
- Award
Share Option
2020-03-13+75,000→ 75,000 totalExercise: $15.52Exp: 2030-03-12→ Class A Common Shares (75,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 13, 2020.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001794636
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:22 PM ET
- Size
- 5.4 KB